Article
The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders
11 Nov 2014
Abstract excerpt
Elevated whole-blood serotonin and decreased plasma melatonin (a circadian synchronizer hormone that derives from serotonin) have been reported independently in patients with autism spectrum disorders (ASDs). Here, we explored, in parallel, serotonin, melatonin and the intermediate N-acetylserotonin (NAS) in a large cohort of patients with ASD and their relatives. We then investigated the clinical correlates of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
